ArticleJournal for immunotherapy of cancer2023

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.

Joao V Alessi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.